Package 70748-355-01

{"route": ["ORAL"], "spl_id": "1f47ffee-bd05-4c0e-a399-b6961cc80b34", "openfda": {"nui": ["N0000175635", "N0000175637"], "upc": ["0370748355015"], "unii": ["9NDF7JZ4M3"], "rxcui": ["2588062"], "spl_set_id": ["b0306b06-d8cf-48de-9e93-57d77e4e98f5"], "pharm_class_epc": ["Factor Xa Inhibitor [EPC]"], "pharm_class_moa": ["Factor Xa Inhibitors [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70748-355-01)  / 1 FOR SUSPENSION in 1 BOTTLE", "package_ndc": "70748-355-01", "marketing_start_date": "20250929"}], "brand_name": "rivaroxaban granule", "product_id": "70748-355_1f47ffee-bd05-4c0e-a399-b6961cc80b34", "dosage_form": "FOR SUSPENSION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "70748-355", "generic_name": "rivaroxaban granule", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "rivaroxaban granule", "active_ingredients": [{"name": "RIVAROXABAN", "strength": "155 mg/1"}], "application_number": "ANDA218195", "marketing_category": "ANDA", "marketing_start_date": "20250929", "listing_expiration_date": "20261231"}